A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis
Clinical trial NCT06587685 · RECRUITING
Trial details
- NCT number
- NCT06587685
- Sponsor
- Prime Gene Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2024-11-19
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.